How should therapeutic information be transferred to users?

被引:4
作者
Boissel, JP [1 ]
Haugh, M [1 ]
Fardeheb, M [1 ]
Nony, P [1 ]
Gueyffier, F [1 ]
Strang, N [1 ]
机构
[1] Univ Lyon 1, RTH Leannec Sch Med, Dept Clin Pharmacol, EA 643, F-69376 Lyon 08, France
关键词
evidence-based medicine; guidelines; messages;
D O I
10.1046/j.1472-8206.2003.00161.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Without an efficient solution to the problems that prevent prescribers and consumers having easy access to published and unpublished evidence, Evidence-Based Medicine will never become a reality. Among the problems, dissemination of the summarized evidence is a major one. It involves representing the summarized evidence in a format that corresponds to the users' needs and knowledge, interpreting it within the context of other related evidence, putting it in perspective, and then delivering it physically to the users at the appropriate time. The current formats, vehicles and representation models, e.g. those for guidelines or textbooks, do not seem efficient enough to fill in the gap of knowledge. We suggest that a new approach is possible by reducing the transferred information to its core and integrating it through appropriate representation models into the doctor's decision-making process.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 70 条
[1]  
[Anonymous], BMJ
[2]   A COMPARISON OF RESULTS OF METAANALYSES OF RANDOMIZED CONTROL TRIALS AND RECOMMENDATIONS OF CLINICAL EXPERTS - TREATMENTS FOR MYOCARDIAL-INFARCTION [J].
ANTMAN, EM ;
LAU, J ;
KUPELNICK, B ;
MOSTELLER, F ;
CHALMERS, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (02) :240-248
[3]  
Arends LR, 2000, STAT MED, V19, P3497, DOI 10.1002/1097-0258(20001230)19:24<3497::AID-SIM830>3.0.CO
[4]  
2-H
[5]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[6]   COMPLETENESS OF REPORTING TRIAL RESULTS - EFFECT ON PHYSICIANS WILLINGNESS TO PRESCRIBE [J].
BOBBIO, M ;
DEMICHELIS, B ;
GIUSTETTO, G .
LANCET, 1994, 343 (8907) :1209-1211
[7]   The use of drug information sources by physicians: Development of a data-generating methodology [J].
Boerkamp, EJC ;
Haaijer-Ruskamp, FM ;
Reuyl, JC ;
Versluis, A .
SOCIAL SCIENCE & MEDICINE, 1996, 42 (03) :379-388
[8]  
Boissel J.-P., 1992, Advances in medical informatics: results of the AIM exploratory action, P349
[9]  
Boissel J P, 1999, Evid Based Cardiovasc Med, V3, P1, DOI 10.1054/ebcm.1999.0200
[10]  
BOISSEL JP, 1989, CONTROL CLIN TRIALS, V10, pS120